Loading…
Boston Scientific announced a partial tender offer to acquire up to 203,702,962 shares (65% equity) of Acandis Holdings Limited at HK$20 per share, with a maximum offer value of approximately HK$4.07 billion. The offer includes a strategic collaboration in China.